Business & Money Teva schizophrenia drug Uzedy reduces relapse risk up to 80% (NYSE:TEVA) May 20, 2023 0 FacebookTwitterPinterestWhatsApp Teva long-acting schizophrenia drug Uzedy reduces relapse risk up to 80% Source link
